The numerous research opportunities available at Mount Sinai are a cornerstone of the Hematology/Medical Oncology Fellowship Program. Icahn School of Medicine at Mount Sinai is ranked 13th among medical schools in National Institutes of Health (NIH) funding for 2023. NIH-funded programs train postdoctoral fellows in cancer prevention, epidemiology, basic research, and clinical research.
Fellows have 18 months of protected, mentored research time during the latter half of their fellowship. By the end of the first year of fellowship, fellows identify an area of interest and a mentor and are guided through the process of developing a research project. Our expectation is that fellow research projects will result in presentations at national conferences and publications and will equip fellows to apply for mentored training grants and other funding to allow them to further develop their interests and foster careers as academic leaders and independent investigators. Fellows are able to choose from a broad range of faculty mentors focusing on a diverse array of research (including basic science, translational, clinical, outcomes, quality improvement, and medical education) within the Division of Hematology/Medical Oncology, Tisch Cancer Institute or other institutes within The Icahn School of Medicine at Mount Sinai. To further guide fellows and their faculty mentors, Fellow Research Guidelines have been developed and Research Advisory Committees formed to outline expectations between mentors and mentees, provide timelines for research plans, progress reports, presentations and publications. Opportunities for advanced training in clinical research through the Masters in Clinical Research (MSCR) or Masters in Public Health (MPH) through the Graduate School for Biomedical Science at the Icahn School of Medicine are also available.